Arizona AG allocates $4M from pharmaceutical settlements to fight opioid crisis
Oct 13, 2022, 8:00 PM
PHOENIX – The Arizona Attorney General’s Office announced Thursday it is making $4 million in grants available to organizations fighting the opioid crisis across the state.
The money comes from settlements with four pharmaceutical companies: Cardinal, McKesson, AmerisourceBergen and Johnson & Johnson. The state secured consent judgments this year with the companies for $540 million to be paid over 18 years and used for opioid treatment, prevention and education.
They funds are available through three pools: $2 million for 13 rural counties, $1 million for large counties (Maricopa and Pima) and $1 million for medically underserved populations statewide.
The grants can be used for several purposes, including opioid use disorder treatment, support for people in treatment and recovery, and preventing the misuse of opioids.
Nonprofits, for-profit organizations, faith-based organizations and community coalitions can submit grant applications through Nov. 28.
“While opioids have not recently received as much media attention as other public health issues, we can never forget those that have been devastated by this epidemic,” Attorney General Mark Brnovich said in a press release. “The distribution of these grants should greatly assist many Arizonans on the road to recovery and well-being.”